US FDA approves Axsome Therapeutics' migraine drug
The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.
US FDA identifies cybersecurity risks in certain patient monitors
The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks associated with certain patient monitors from Contec and Epsimed and urged healthcare facilities to mitigate those risks.
Sunscreen Recalled Nationwide as FDA Sets Risk Level
Lay’s recall increased to highest level, could cause ‘death’: FDA
Chocolate recall upgraded to highest risk level, FDA announces
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,
Broccoli Recall Update as FDA Sets Highest Risk Level Over Bacteria Fears
Broccoli florets sold in Walmart stores across 20 states that were recalled over bacterial contamination fears have been given the U.S. Food and Drug Administration (FDA)'s highest risk level.
Sorbet Recall Update As FDA Sets Highest Risk Level
A sorbet-filled mochi recalled due to an undeclared allergen has been given the U.S. Food and Drug Administration (FDA)'s highest risk level. The My Mochi Ice Cream Company of Vernon, California, recalled 1,
Trump admin's FDA withdraws proposed federal rule to ban menthol cigarettes
Trump's FDA moved to squash a proposed rule to ban menthol cigarettes just one day after the president was sworn in, angering anti-smoking advocates.
Lay’s potato chip recall elevated to FDA’s highest-risk classification
The FDA has upgraded a recall of Lay’s Potato Chips to the highest level possible, meaning consuming the chips will cause adverse health consequences. In December, Texas-based food manufacturer Frito Lay recalled a limited number of Lay’s Classic 13oz because the product could contain undeclared milk ingredients.
Ticker: FDA puts out alarming chocolate recall; Tesla’s fourth-quarter results fall short; Meta posts sharply higher Q4 profit
Ticker: FDA puts out alarming chocolate recall; Tesla’s fourth-quarter results fall short; Meta posts sharply higher Q4 profit
Axsome gets FDA approval for Symbravo for migraine
Axsome Therapeutics (NASDAQ:AXSM) has received FDA approval for its drug Symbravo for the acute treatment of migraine with or without aura in adults. Symbravo, a combination of meloxicam and rizatriptan,
Opinion
The Highland County Press47mOpinion
Why does the NYT continue print false information about RFK Jr.?
Any NYT reader looking at the buzzy front page headline below would immediately think that Robert F. Kennedy Jr. is a madman. Can he really be an advocate for repealing the polio vaccine, a disease that has killed and crippled tens of millions of kids?
$1,000 invested in Mesoblast shares at the start of 2024 is now worth…
Did this biotech company deliver the goods for investors? Let's see what a $1,000 investment would be worth. The post $1,000 invested in Mesoblast shares at the start of 2024 is now worth… appeared first on The Motley Fool Australia.